Casanillo, Aida .
HRN: 05-53-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2024
CEFUROXIME 1.5GM (VIAL)
08/28/2024
08/31/2024
IV
1.5g
Q8H
S/P Thyroidectomy
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes